These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 9537418)

  • 21. Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin.
    Grönholm M; Sainio M; Zhao F; Heiska L; Vaheri A; Carpén O
    J Cell Sci; 1999 Mar; 112 ( Pt 6)():895-904. PubMed ID: 10036239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neurofibromatosis type 2 (central neurofibromatosis or bilateral acoustic neuromas, vestibular schwannomas): from phenotype to gene].
    Sabol Z; Kipke-Sabol L; Miklić P; Hajnsek-Propadalo S; Sabol F
    Lijec Vjesn; 2006; 128(9-10):309-16. PubMed ID: 17128670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The neurofibromatosis 2 (NF2) tumour suppressor gene: implications beyond the hereditary tumour syndrome?
    Kley N; Seizinger BR
    Cancer Surv; 1995; 25():207-18. PubMed ID: 8718520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Schwannomin inhibits tumorigenesis through direct interaction with the eukaryotic initiation factor subunit c (eIF3c).
    Scoles DR; Yong WH; Qin Y; Wawrowsky K; Pulst SM
    Hum Mol Genet; 2006 Apr; 15(7):1059-70. PubMed ID: 16497727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain.
    Koga H; Araki N; Takeshima H; Nishi T; Hirota T; Kimura Y; Nakao M; Saya H
    Oncogene; 1998 Aug; 17(7):801-10. PubMed ID: 9779996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin.
    Meng JJ; Lowrie DJ; Sun H; Dorsey E; Pelton PD; Bashour AM; Groden J; Ratner N; Ip W
    J Neurosci Res; 2000 Nov; 62(4):491-502. PubMed ID: 11070492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of cellular proteins that interact with the NF2 tumor suppressor gene product.
    Takeshima H; Izawa I; Lee PS; Safdar N; Levin VA; Saya H
    Oncogene; 1994 Aug; 9(8):2135-44. PubMed ID: 8035998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NF2: the wizardry of merlin.
    Xiao GH; Chernoff J; Testa JR
    Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Schwannomin: new insights into this member of the band 4.1 superfamily.
    Belliveau MJ; Lutchman M; Claudio JO; Marineau C; Rouleau GA
    Biochem Cell Biol; 1995; 73(9-10):733-7. PubMed ID: 8714694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magicin, a novel cytoskeletal protein associates with the NF2 tumor suppressor merlin and Grb2.
    Wiederhold T; Lee MF; James M; Neujahr R; Smith N; Murthy A; Hartwig J; Gusella JF; Ramesh V
    Oncogene; 2004 Nov; 23(54):8815-25. PubMed ID: 15467741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid-binding role of betaII-spectrin ankyrin-binding domain.
    Bok E; Plazuk E; Hryniewicz-Jankowska A; Chorzalska A; Szmaj A; Dubielecka PM; Stebelska K; Diakowski W; Lisowski M; Langner M; Sikorski AF
    Cell Biol Int; 2007 Dec; 31(12):1482-94. PubMed ID: 17716929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectrin oligomerization is cooperatively coupled to membrane assembly: a linkage targeted by many hereditary hemolytic anemias?
    Giorgi M; Cianci CD; Gallagher PG; Morrow JS
    Exp Mol Pathol; 2001 Jun; 70(3):215-30. PubMed ID: 11418000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The merlin interacting proteins reveal multiple targets for NF2 therapy.
    Scoles DR
    Biochim Biophys Acta; 2008 Jan; 1785(1):32-54. PubMed ID: 17980164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Normal membrane localization and actin association of the NF2 tumor suppressor protein are dependent on folding of its N-terminal domain.
    Brault E; Gautreau A; Lamarine M; Callebaut I; Thomas G; Goutebroze L
    J Cell Sci; 2001 May; 114(Pt 10):1901-12. PubMed ID: 11329377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of schwannomin in lens and Schwann cells.
    Claudio JO; Veneziale RW; Menko AS; Rouleau GA
    Neuroreport; 1997 May; 8(8):2025-30. PubMed ID: 9223096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative analysis of neurofibromatosis type 2 gene transcripts in meningiomas supports the concept of distinct molecular variants.
    Wellenreuther R; Waha A; Vogel Y; Lenartz D; Schramm J; Wiestler OD; von Deimling A
    Lab Invest; 1997 Dec; 77(6):601-6. PubMed ID: 9426397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphorylation of the NF2 tumor suppressor in Schwann cells is mediated by Cdc42-Pak and requires paxillin binding.
    Thaxton C; Lopera J; Bott M; Baldwin ME; Kalidas P; Fernandez-Valle C
    Mol Cell Neurosci; 2007 Feb; 34(2):231-42. PubMed ID: 17175165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression level, subcellular distribution and rho-GDI binding affinity of merlin in comparison with Ezrin/Radixin/Moesin proteins.
    Maeda M; Matsui T; Imamura M; Tsukita S; Tsukita S
    Oncogene; 1999 Aug; 18(34):4788-97. PubMed ID: 10490812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical detection of schwannomin and neurofibromin in vestibular schwannomas, ependymomas and meningiomas.
    Huynh DP; Mautner V; Baser ME; Stavrou D; Pulst SM
    J Neuropathol Exp Neurol; 1997 Apr; 56(4):382-90. PubMed ID: 9100669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced expression of schwannomin/merlin in human sporadic meningiomas.
    Lee JH; Sundaram V; Stein DJ; Kinney SE; Stacey DW; Golubić M
    Neurosurgery; 1997 Mar; 40(3):578-87. PubMed ID: 9055299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.